• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. Jan 4, 2000; 97(1): 412–417.
PMCID: PMC26677
Microbiology

Identification of bdm-1, a gene involved in G protein β-subunit function and α-subunit accumulation

Abstract

Targeted disruption of Gα and Gβ genes has established the requirement of an intact G protein signaling pathway for optimal execution of several important physiological processes, including pathogenesis, in the chestnut blight fungus Cryphonectria parasitica. We now report the identification of a G protein signal transduction component, beta disruption mimic factor-1, BDM-1. Disruption of the corresponding gene, bdm-1, resulted in a phenotype indistinguishable from that previously observed after disruption of the Gβ subunit gene, cpgb-1. The BDM-1 deduced amino acid sequence contained several significant clusters of identity with mammalian phosducin, including a domain corresponding to a highly conserved 11-amino acid stretch that has been implicated in binding to the Gβγ dimer and two regions of defined Gβ/phosducin contact points. Unlike the negative regulatory function proposed for mammalian phosducin, the genetic data presented in this report suggest that BDM-1 is required for or facilitates Gβ function. Moreover, disruption of either bdm-1 or cpgb-1 resulted in a significant, posttranscriptional reduction in the accumulation of CPG-1, a key Gα subunit required for a range of vital physiological processes.

Keywords: Cryphonectria parasitica, fungal pathogenesis, phosducin

Heterotrimeric GTP-binding proteins are a highly conserved family of eukaryotic regulatory complexes composed of three subunits, designated α, β, and γ, that function to couple transmembrane receptors with intracellular effectors (1). Receptor activation by a variety of environmental stimuli results in the exchange of bound GDP for GTP, promoting disassociation of the three subunits as α-GTP and a βγ heterodimer, both of which interact with and alter the activity of a diverse set of effector molecules, e.g., adenylyl cyclase, phospholipase C, and ion channels (2, 3). Hydrolysis of GTP to GDP by an intrinsic Gα-associated GTPase activity results in reassociation of the α-subunit with the βγ heterodimer and signal termination.

Although signal specificity resides primarily at the receptor level (4), recent studies have identified a number of regulatory proteins that act directly on the G protein subunits to regulate various steps in the GTPase cycle. For example, Strittmatter et al. (5) reported acceleration of guanine nucleotide release mediated by the growth cone protein GAP-43. The regulators of G protein signaling family of proteins has been shown to activate the intrinsic GTPase activity of several Gα subunits (68). Signaling through the βγ heterodimer has been shown to be modulated by binding proteins such as the β-adrenergic receptor kinases (911) and phosducin (12, 13).

The importance of G protein signaling in regulating diverse vital biological processes in filamentous fungi is now well established (1421). Targeted disruption of Gα subunit genes for a number of pathogenic fungi has indicated a broad role for G protein signaling in fungal virulence and dependent developmental processes such as infection structure formation, mycelial growth, and reproduction (14, 15, 19, 20). Recent progress in cloning and characterization of filamentous fungal genes encoding other G protein subunits and regulatory proteins support this view, e.g., the Gβ subunit gene cpgb-1 from Cryphonectria parasitica (18) and the regulator of G protein signaling protein flbA from Aspergillus nidulans (22).

We now report the identification of a C. parasitica gene encoding a component of G protein signaling, BDM-1, that is required for virulence and that has clusters of amino acid identity with mammalian phosducin. Although mammalian phosducins are postulated to modulate G protein signaling negatively by sequestering Gβγ heterodimers (4, 13, 23, 24), disruption of bdm-1 produced a phenocopy of C. parasitica Gβ null mutants, suggesting a role in facilitating Gβ function. Additionally, disruption of either bdm-1 or the Gβ gene cpgb-1 caused a significant reduction in the accumulation of the key Gα subunit CPG-1 but not of CPG-1 mRNA. These results are discussed in terms of current views of the in vivo role of mammalian phosducin and the possibility that BDM-1 represents the prototype of a previously unidentified family of positive regulators of Gβ function. The increasing evidence for posttranscriptional regulation of G protein signaling in fungal processes ranging from reproduction to virulence is also considered.

Materials and Methods

Fungal Strains and Growth Conditions.

C. parasitica strains EP155 (ATCC 38755, virulent) and ΔGβ-a (strain EP155 in which the Gβ gene cpgb-1 is disrupted; ref. 18) were maintained and propagated on potato dextrose agar (PDA; Difco) as described (25). A C. parasitica strain with a phenotype indistinguishable from ΔGβ-a, designated bdmA, was obtained during attempts to disrupt the gene that encodes the general amino acid control transcriptional activator CPC-1 (26).

Construction of a Cosmid Library.

Genomic DNA was extracted and purified from 7-day-old mycelia of C. parasitica strain EP155 grown at room temperature (23°C) on cellophane-covered PDA as described (27). DNA was partially digested with restriction enzyme Cfr10 I. The cosmid vector pCOSNBn1 was constructed by replacing the SmaI–SalI fragment of pWE15 (Stratagene) with the Neurospora crassa benomyl-resistance gene (28). The Cfr10 I-digested genomic DNA was partially filled in with dCTP by using the Klenow fragment of Escherichia coli DNA polymerase I. The NotI-digested vector pCOSNBn1 was also partially filled in with dGTP. After ligating the cosmid vector and Cfr10 I-digested insert, the DNA was treated with the Giga Pack III XL packaging extract (Stratagene) followed by transfection into E. coli XL-I Blue MR cells.

Complementation Cloning of the bdmA Locus.

Mutant bdmA spheroplasts were prepared and transformed with cosmid library DNA as described by Churchill et al. (29). A single benomyl-resistant transformant with the wild-type (EP155)-like phenotype was purified to nuclear homogeneity by collecting uninuclear single conidial isolates capable of growing on PDA-benomyl plates. To recover the integrated complementing cosmid DNA from the transformant, genomic DNA was extracted, treated with RNase A, precipitated with polyethylene glycol/NaCl, packaged (3 μg/reaction) with a Giga Pack III XL packaging extract, and transfected into E. coli XL-I Blue MR cells.

Nucleic Acid Preparation and Analysis.

Total nucleic acids were extracted from approximately 3 g of 7-day-old C. parasitica mycelia grown on cellophane-covered PDA plates as described above. Genomic DNA and single-stranded RNA fractions used for Southern and Northern blot analyses, respectively, were prepared according to the method described by Choi et al. (27). Standard protocols (30) were used for both DNA and RNA blotting analyses with slight modifications (18).

Nucleotide Sequence Accession Number.

The GenBank accession number for the nucleotide sequence of bdm-1 is AF140555.

Results

Phenotypic Characterization of bdmA.

We previously reported that disruption of the C. parasitica Gβ subunit gene cpgb-1 resulted in several phenotypic changes that included a flat colony morphology distinguished by densely bundled, sparsely branched, parallel arrays of hyphae, reduced orange pigment production, a 5–6 log reduction in asexual sporulation, and significantly reduced virulence (18). In a screen designed to disrupt the C. parasitica general amino acid regulatory gene cpc-1, we unexpectedly identified a mutant, subsequently designated bdmA (beta disruption mimic mutant A), that had a colony morphology indistinguishable from the cpgb-1 disruptants (Fig. (Fig.1).1). Phenotypic similarities extended to reduced virulence (Table (Table1),1), reduced conidiation, and increased growth rates under a variety of growth conditions (data not shown). Microscopic examination of bdmA hyphae also revealed the distinctive bundled parallel arrays of hyphae with significantly reduced branch points as previously shown for the cpgb-1 disruptants (see figure 6 in ref. 18).

Figure 1
Comparison of colony morphologies for wild-type C. parasitica strain EP155 and corresponding mutants, heterokaryon, and complemented strains. When grown on PDA, mutant bdmA had a phenotype indistinguishable from that previously reported (18) for Gβ ...
Table 1
Mean canker areas induced on dormant chestnut stems by C. parasitica strains

Although bdmA phenocopied cpgb-1 disruptants, heterokaryons formed by anastomosis of the two strains had a near wild-type morphology, indicating that the two mutations fall within distinct complementation groups (Fig. (Fig.1).1). Southern, Northern, and Western blot analyses confirmed that bdmA contained an intact cpgb-1 locus and wild-type levels of cpgb-1 mRNA and CPGB-1 protein (Fig. (Fig.2).2). Hybridization analysis with a probe specific for the cpc-1 disruption vector revealed a complex hybridization pattern (Fig. (Fig.33B) consistent with the presence of multiple integrated copies. This level of complexity necessitated mapping of the bdmA locus by complementation with a C. parasitica cosmid library.

Figure 2
Analysis of C. parasitica Gβ subunit CPGB-1 genomic DNA, mRNA, and protein in wild-type strain EP155 and corresponding mutants cultured under identical conditions. (A) Southern blots were performed on 10 μg of PstI-digested genomic DNA ...
Figure 3
Complementation mapping and disruption of bdm-1. (A1) Restriction map of cosmid clone rescued from the chromosome of a bdmA complemented transformant. (A2) Detailed organization of bdm-1 in the context of the 6.5-kb KpnI bdmA complementing fragment. The ...

Complementation Mapping of bdm-1.

The cosmid rescued from chromosomal DNA of a complemented transformant with the wild-type phenotype (Fig. (Fig.1)1) contained an insert of approximately 35 kb. Transformation with portions of the original insert subcloned adjacent to the benomyl-resistance gene in a modified pBluescript II SK(+) vector (Stratagene) led to the identification of a 6.5-kb KpnI fragment able to confer the wild-type EP155-like phenotype (Fig. (Fig.33A). Because the two subcloned XbaI–KpnI fragments derived from this 6.5-kb KpnI complementing fragment (Fig. (Fig.33A) failed to complement bdmA, the region flanking the XbaI site and a cDNA clone corresponding to that region were subjected to sequence analysis. Computer-assisted analysis of the sequence information revealed an ORF encoding a deduced protein of 32,885 Da. Two introns were identified within this gene, now designated bdm-1: one of 102 nt within the 5′ noncoding leader and one of 56 nt near the middle of the coding domain (Fig. (Fig.33A).

To confirm that a mutated bdm-1 allele is responsible for the bdmA phenotype, the gene was subjected to independent targeted disruption. The 6.5-kb complementing KpnI fragment was cloned into pBluescript II SK(+) and modified by replacing the 1.5-kb BamHI–SmaI fragment containing the entire bdm-1 coding region with a 2.3-kb hygromycin-resistance gene cassette (Fig. (Fig.33A). The modified 7.3-kb fragment released by KpnI digestion was used to transform wild-type strain EP155. Transformants with the bdmA phenotype (Fig. (Fig.1)1) were recovered at a rate of 1 for every 20 hygromycin-resistant transformants. Southern blot analysis of putative disruptants revealed a hybridization pattern consistent with the predicted disruption of the bdm-1 locus (Fig. (Fig.33 B and C). The absence of bdm-1 mRNA was confirmed by Northern analysis (Fig. (Fig.33D). The Δbdm-1 disruptants were also found to have an intact cpgb-1 locus and to produce wild-type levels of cpgb-1 mRNA and CPGB-1 protein (Fig. (Fig.2).2). These disruptants were also indistinguishable from bdmA and Δcpgb-1 in terms of growth characteristics (Fig. (Fig.1)1) and a significantly reduced level of virulence (Table (Table1).1). Additional confirmation was obtained by rescuing a bdm-1 disruptant and bdmA by transformation with bdm-1 cDNA under the control of the C. parasitica glyceraldehyde-3-phosphate dehydrogenase promoter in the standard C. parasitica transformation vector pCPXHY1 (31, 32) modified to contain a benomyl-resistance gene (data not shown). These combined results suggest that BDM-1 is required for, or facilitates, Gβ function and establish a role for this protein in the regulation of fungal virulence.

Database homology search analysis (blastp) revealed mammalian phosducins as having the highest level of amino acid sequence identity with the newly identified gene. This result was intriguing, given the reports that this family of proteins also modulates G protein signal transduction, primarily by binding to Gβγ subunits (13, 23, 24, 33). As shown in Fig. Fig.4,4, optimal alignment of the two proteins excluded the negatively charged 64-residue N-terminal portion of the C. parasitica protein. Although the overall level of sequence identity is low (23%), further inspection revealed several clusters of reasonably high similarity. For example, residues 83–95 had 69% identity; residues 188–205 showed 50% identity and 78% conservation; and residues 247–261 had 40% identity and 73% conservation (Fig. (Fig.4).4). Interestingly, two of these clusters corresponded to regions of phosducin that contact the Gβ subunit as determined by x-ray-crystallography (24). The N-terminal BDM-1 cluster, amino acids 83–95, contained identical amino acid residues at eight positions within an 11-amino acid stretch, TGPKGVINDWR, that is highly conserved in mammalian phosducin and phosducin-like proteins (34, 35). This 11-amino acid stretch lies within a domain containing eight Gβ contact points, six of which are retained in the BDM-1 sequence. The C-terminal cluster, amino acids 247–261, corresponds to the C-terminal phosducin/Gβγ interface and shares identical residues at two of the five contacts and conserved residues at two additional contact points.

Figure 4
Alignment of the deduced C. parasitica BDM-1 amino acid sequence (GenBank accession no. AF140555) with that of human retinal phosducin (SWISS PROT accession ...

Disruption of bdm-1 or cpgb-1 Results in Posttranscriptional Reduction in Accumulation Of Gα Subunit CPG-1.

Gao and Nuss (36) recently reported that mutation of the putative myristoylation site (Gly-2) of the C. parasitica Gα subunit CPG-1 resulted in complex phenotypic changes and a 5-fold increase in CPG-1 accumulation. Moreover, Northern analysis of cpg-1 mRNA revealed that this increase was regulated at the posttranscriptional level, i.e., cpg-1 mRNA was found to be present at wild-type levels. This observation stimulated an examination of whether the disruption of the Gβ gene and subsequent loss of CPGB-1 protein accumulation would have an effect on the accumulation of the presumptive Gα partner, CPG-1. As indicated in Fig. Fig.55B, CPG-1 levels are consistently reduced to ≈10% of the wild-type level in the cpgb-1 disruptant. Interestingly, a nearly identical result was obtained for the bdm-1 disruptant. As shown in Fig. Fig.55A, the level of cpg-1 mRNA is not reduced but slightly increased in the Gβ null mutant and found at wild-type levels in the bdm-1 disruptant and in bdmA. Note additionally in Fig. Fig.2,2, that CPGB-1 accumulation is not altered in bdm-1 disruptants. Thus, the phenotypic similarities resulting from cpgb-1 and bdm-1 disruption extend to a posttranscriptional reduction in Gα CPG-1 accumulation.

Figure 5
Analysis of C. parasitica Gα subunit CPG-1 mRNA and protein accumulation in wild-type strain EP155 and corresponding mutants cultured under identical growth conditions. (A) Northern hybridization analysis of cpg-1 transcript accumulation in wild-type ...

Discussion

The observation that bdm-1 disruption phenocopies cpgb-1 null mutants strongly suggests that this newly identified gene encodes a positive regulator of Gβ function. Consistent with a role for BDM-1 in Gβ function, the deduced BDM-1 amino acid sequence contained several clusters of identity with mammalian phosducin that correspond to regions of physical interactions between the latter protein and Gβ subunit. The level of identity within the N-terminal cluster, BDM-1 amino acids 83–95, is provocative in that in addition to having identical residues at six of eight Gβγ contact points, the BDM-1 sequence also shows identity at eight positions of a contiguous 11-residue peptide, TGPKGVINDWR, that is absolutely conserved in all mammalian phosducins (34, 35).

Mammalian phosducins are generally thought to act as negative regulators of G protein signaling. First isolated as a complex with the transducin Gβγ heterodimer Tβγ from the retina (23), where it is present in high concentration, phosducin is postulated to reduce signal amplification by sequestering Tβγ subunits, thereby preventing reassociation with the inactive GDP-bound form of the transducin Gα subunit Tα (13, 37). The latter step is essential for reactivation. Phosducin and phosducin-like proteins were subsequently reported to be expressed in numerous tissues (38, 39) and to modulate G protein signaling by competing with a variety of other Gβγ binding proteins, e.g., the β-adrenergic receptor kinase (40) and the olfactory receptor-specific kinase GRK3 (33). Binding of phosducin to Gβγ subunits is, in turn, regulated by cAMP-dependent phosphorylation at Ser-73 (12, 37, 41, 42), with the phosphorylated form having a much reduced affinity for the Gβγ dimer. Phosducin has also been reported to interact with Gα subunits, resulting in reduced GTPase activity or rate of GDP release (12, 13).

The positive regulatory role proposed for BDM-1 raises intriguing questions regarding currently envisioned in vivo roles of mammalian phosducins and the potential for a family of BDM-1 homologs in higher eukaryotes. Evidence supporting the model for mammalian phosducin as a negative regulator of Gβγ signaling is based almost exclusively on data from in vitro biochemical or transient expression studies. There have been no gene disruption experiments like those performed for BDM-1. In this regard, Lem et al. (43) recently reported a surprising observation in rhodopsin knockout mice. Transgenic mice containing a single opsin gene had an accelerated recovery time to light response relative to wild-type mice. Measurement of eight different phototransduction proteins confirmed wild-type levels, except for a 50% increase in the level of phosducin. Because photoresponse recovery depends on reunion of the Tα subunit with the Tβγ subunit, a step that is proposed to be negatively regulated by phosducin, the increased ratio of phosducin to Tβγ should have caused a delay rather than an acceleration of the photoresponse recovery. Such unanticipated in vivo results suggest that caution should be exercised when considering interpretations of phosducin function based predominantly on in vitro and transient transfection data. The phenotypic consequences associated with the disruption of mammalian phosducin will be of particular interest. The apparent opposite functional roles proposed for mammalian phosducin and fungal BDM-1 also raise the possibility that the latter protein represents the prototype of a previously unidentified family of positive regulators of Gβ function that is perhaps ancestrally related to mammalian phosducin. Like mammalian phosducin, such regulatory proteins may also represent potential targets for the development of G protein modulating agents of therapeutic value (44).

Similarities between the bdm-1 disruptant and the Gβ null mutant extended to the reduced accumulation of the Gα subunit CPG-1. The literature contains several examples of coordinated regulation of G protein subunit accumulation at varying levels (4547). However, analogies to the 90% posttranscriptional reduction in CPG-1 accumulation observed on disruption of either bdm-1 or cpgb-1 (Fig. (Fig.5)5) are not apparent in the literature. Altered accumulation of CPG-1 levels has been reported previously under several apparently unrelated conditions. A decrease in CPG-1 levels was observed after hypovirus CHV1-EP713 infection and on cosuppression as a result of stable transformation with a cpg-1 sense copy (48). Mutation of the putative myristoylation site (Gly-2) resulted in a substantial increase in CPG-1 accumulation (36). As was observed for bdm-1 and cpgb-1 disruptants, mutation of the putative myristoylation site or alterations in CPG-1 accumulation after hypovirus infection were regulated at the posttranscriptional level (ref. 36 and data not shown, respectively). This apparent propensity of CPG-1 for posttranscriptional regulation is of considerable importance, because vital processes ranging from mycelial growth to asexual sporulation to virulence are surprisingly sensitive to even minor modulations of G protein signaling (15, 18, 36). A clear understanding of the mechanisms by which BDM-1 affects Gα stability and facilitates Gβ function will provide important advances in the areas of C. parasitica biology and fungal pathogenesis and is likely to have broad implications for the general field of G protein signal transduction.

Acknowledgments

This work was supported by National Institutes of Health Grant GM55981 to D.L.N.

Abbreviations

PDA
potato dextrose agar
kb
kilobase

Footnotes

This paper was submitted directly (Track II) to the PNAS office.

Data deposition: The sequence reported in this paper has been deposited in the GenBank database (accession no. AF140555).

References

1. Gilman A G. Annu Rev Biochem. 1987;56:615–649. [PubMed]
2. Clapham D E, Neer E J. Annu Rev Pharmacol Toxicol. 1997;37:167–203. [PubMed]
3. Hamm H, Gilchrist A. Curr Opin Cell Biol. 1996;8:189–196. [PubMed]
4. Bockaert J, Pin J P. EMBO J. 1999;18:1723–1729. [PMC free article] [PubMed]
5. Strittmatter S M, Valenzuela D, Sudo Y, Linder M E, Fishman M C. J Biol Chem. 1991;266:22465–22471. [PubMed]
6. Berman D M, Wilkie T M, Gilman A G. Cell. 1996;86:445–452. [PubMed]
7. Hunt T W, Fields T A, Casey P J, Peralta E G. Nature (London) 1996;383:175–177. [PubMed]
8. Watson N, Linder M E, Druey K M, Kehrl J H, Blumer K J. Nature (London) 1996;383:172–175. [PubMed]
9. Koch W J, Inglese T, Stone W C, Lefkowitz R J. J Biol Chem. 1993;268:8256–8260. [PubMed]
10. Müller S, Hekman M, Lohse M J. Proc Natl Acad Sci USA. 1993;90:10439–10443. [PMC free article] [PubMed]
11. Müller S, Straub A, Schroder S, Bauer P, Lohse M J. J Biol Chem. 1996;271:11781–11786. [PubMed]
12. Bauer P H, Müller S, Puzicha M, Pippig S, Obermaier B, Helmreich E J M, Lohse M J. Nature (London) 1992;358:73–76. [PubMed]
13. Lee R H, Ting T D, Lieberman B S, Tobias D E, Lolley R N, Ho Y-K. J Biol Chem. 1992;267:25104–25112. [PubMed]
14. Alspaugh J A, Perfect J R, Heitman J. Genes Dev. 1997;11:3206–3216. [PMC free article] [PubMed]
15. Gao S, Nuss D L. Proc Natl Acad Sci USA. 1996;93:14122–14127. [PMC free article] [PubMed]
16. Horwitz B A, Sharon A, Shun-Wen L, Ritter V, Sandrock T, Yoder O C, Turgeon B G. Fungal Genet Biol. 1999;26:19–32. [PubMed]
17. Ivey F D, Hodge P N, Turner G E, Borkovich K A. Mol Biol Cell. 1996;7:1283–1297. [PMC free article] [PubMed]
18. Kasahara S, Nuss D. Mol Plant-Microbe Interact. 1997;8:984–993. [PubMed]
19. Liu S, Dean R A. Mol Plant–Microbe Interact. 1997;9:1075–1086. [PubMed]
20. Regenfelder E, Spellig T, Hartmann A, Lauenstein S, Bolker M, Kahmann R. EMBO J. 1997;16:1934–1942. [PMC free article] [PubMed]
21. Turner G E, Borkovich K A. J Biol Chem. 1993;268:14805–14811. [PubMed]
22. Lee B N, Adams T H. Mol Microbiol. 1994;14:323–334. [PubMed]
23. Lee R H, Lieberman B S, Lolley R N. Biochemistry. 1987;26:3983–3990. [PubMed]
24. Gaudet R, Bohm A, Sigler P B. Cell. 1997;87:577–588. [PubMed]
25. Hillman B I, Shapira R, Nuss D L. Phytopathology. 1990;80:950–956.
26. Wang P, Larson T G, Chen C-H, Pawlyk D M, Clark J A, Nuss D L. Fungal Genet Biol. 1998;23:81–94. [PubMed]
27. Choi G H, Larson T G, Nuss D L. Mol Plant–Microbe Interact. 1992;5:119–128. [PubMed]
28. Orbach M J, Porro E B, Yanofsky C. Mol Cell Biol. 1986;6:2452–2461. [PMC free article] [PubMed]
29. Churchill A C L, Ciufetti L M, Hansen D R, Van Etten H D, Van Alfen N K. Curr Genet. 1990;17:25–31.
30. Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd Ed. Plainview, NY: Cold Spring Harbor Lab. Press; 1989.
31. Choi G H, Nuss D L. Science. 1992;257:800–803. [PubMed]
32. Craven M G, Pawlyk D M, Choi G H, Nuss D L. J Virol. 1993;67:6513–6521. [PMC free article] [PubMed]
33. Boekhoff I, Touhara K, Danner S, Inglese J, Lohse M J, Breer H, Lefkowitz R J. J Biol Chem. 1997;272:4604–4612. [PubMed]
34. Miles M F, Barhite S, Sganga M, Elliott M. Proc Natl Acad Sci USA. 1993;90:10831–10835. [PMC free article] [PubMed]
35. Xu J, Wu D, Slepak V Z, Simon M I. Proc Natl Acad Sci USA. 1995;92:2086–2090. [PMC free article] [PubMed]
36. Gao S, Nuss D L. Mol Plant–Microbe Interact. 1998;11:1130–1135. [PubMed]
37. Yoshida T, Willardson B M, Wilkins J F, Jensen G J, Thornton B D, Bitensky M W. J Biol Chem. 1994;269:24050–24057. [PubMed]
38. Danner S, Lohse M J. Proc Natl Acad Sci USA. 1996;93:10145–10150. [PMC free article] [PubMed]
39. Craft C M, Xu J, Slepak V Z, Zhan-Poe X, Zhu X, Brown B, Lolley R N. Biochemistry. 1998;37:15758–15772. [PubMed]
40. Hekman M, Bauer P H, Sohlemann P, Lohse M J. FEBS Lett. 1994;343:120–124. [PubMed]
41. Lee R H, Brown B M, Lolley R N. J Biol Chem. 1990;265:15860–15866. [PubMed]
42. Reig J A, Klein D C. J Biol Chem. 1990;267:5816–5824. [PubMed]
43. Lem J, Krasnoperova N V, Calvert P D, Kosaras B, Cameron D A, Nicolo M, Makino C L, Sidman R L. Proc Natl Acad Sci USA. 1999;96:736–741. [PMC free article] [PubMed]
44. Bluml K, Schnepp W, Schroder S, Beyermann M, Macias M, Oschkinat H, Lohse M J. EMBO J. 1997;16:4908–4915. [PMC free article] [PubMed]
45. Hermouet S, Murakami T, Spiegel A M. FEBS Lett. 1993;327:183–188. [PubMed]
46. Rudolph U, Spicher K, Birnbaumer L. Proc Natl Acad Sci USA. 1996;93:3209–3214. [PMC free article] [PubMed]
47. Simonds W F, Butrynski J E, Gautam N, Unson C G, Spiegel A M. J Biol Chem. 1991;266:5363–5366. [PubMed]
48. Choi G H, Chen B, Nuss D L. Proc Natl Acad Sci USA. 1995;92:305–309. [PMC free article] [PubMed]
49. Gritz L, Davies J. Gene. 1983;25:179–188. [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences
PubReader format: click here to try

Formats:

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...